News Detail - Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler signs agreement to sell its cyclotron division to Alliance Medical

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Mergers & Acquisitions/Disposal

05-May-2017 / 13:33 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Insider information pursuant to Article 17 MAR

Eckert & Ziegler signs agreement to sell its cyclotron division to Alliance Medical

Berlin, 5 May, 2017 - Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG (ISIN DE 0005659700), signed an agreement today on the sale of its entire cyclotron division to Alliance Medical Ltd. Eckert & Ziegler will receive a payment in cash in the amount of EUR 13,0 million in return. The corporate division being sold generated sales of around EUR 18 million in 2016, accounting for approximately 13 % of consolidated sales and only a small profit contribution. The sale will be effective as of today.

For further information or questions, please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Phone: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de


Information and Explanation of the Issuer to this News:

Additional text:

'As part of the realignment of the Radiopharma segment, the Executive Board has decided to focus on globally scalable products and services', explained Dr. André Heß, Member of the Executive Board of Eckert & Ziegler AG and Head of the Radiopharma segment. 'Our cyclotron based products, which are sold in Germany and some neighboring regions only, do not fit into this category. Due to their short half life cyclotron based products can only be sold within driving distance from the production facilities. Growth potential is therefore limited. Building new cyclotrons in other parts of the world only offers low returns on investment, since competitors already have strong positions in nearly all foreign markets. Well established players such as Alliance Medical, by contrast, who run cyclotron chains in different countries, can realize synergy effects to their core business through this acquisition'.

Howard Marsh, Head of Alliance Medicals Radiopharmacy division said: 'The acquisition of Eckert & Zieglers cylclotron division further extends our Molecular Imaging presence in Northern Europe, supplementing both our PET/CT scanning services across the region as well as our radiopharmacy facilities in the UK and Italy. By creating the largest European integrated Radiotracer supply and Imaging organization, we are able to offer a range of solutions to meet all customers needs.'

About Eckert & Ziegler
With around 670 employees, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world's largest providers of isotope components for radiation therapy and nuclear medicine.
Contributing to saving lives.

About Alliance Medical
Alliance Medical is Europe's leading diagnostic and molecular imaging services provider delivering high quality diagnostic solutions in partnership with public and private organisations.


05-May-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this